Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OLE: Lopinavir/Ritonavir + Lamivudine Simplification in HIV
NCT01471821Phase 4Completed
- Start
- Oct 2011
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir, ritonavir, lamivudine in human immunodeficiency virus infection (HIV). Started Oct 2011; status: completed.
02
Drugs
lopinavirritonavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01471821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471821.